Insider · CIK 0001647511
Alfonzo Leon
Files at XRN (Chiron Real Estate Inc.). First filing -, latest -.
Alfonzo Leon files SEC Form 4 as officer at XRN (Chiron Real Estate Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Alfonzo Leon has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | XRN Chiron Real Estate Inc. | AGrant or award LTIP Unit (Right to Buy)derivative | +10,385 | $0.00 | $0 | 101,842 | Feb 25, 2026 |
| Feb 24, 2026 | XRN Chiron Real Estate Inc. | AGrant or award LTIP Unit (Right to Buy)derivative | +3,273 | $0.00 | $0 | 105,115 | Feb 25, 2026 |
| Feb 26, 2025 | XRN Chiron Real Estate Inc. | AGrant or award LTIP Unit (Right to Buy)derivative | +46,069 | $0.00 | $0 | 444,633 | Feb 27, 2025 |
| Feb 26, 2025 | XRN Chiron Real Estate Inc. | AGrant or award LTIP Unit (Right to Buy)derivative | +12,650 | $0.00 | $0 | 457,283 | Feb 27, 2025 |
Questions about Alfonzo Leon
Answered from the filings on this page, as of the latest one.
Is Alfonzo Leon buying or selling?
Alfonzo Leon has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Alfonzo Leon's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alfonzo Leon has 0.
Where does Alfonzo Leon file Form 4?
Alfonzo Leon has filed Form 4 at XRN (Chiron Real Estate Inc.) as CIO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.